Mounjaro 10mg: what happens at this stage of treatment

Step 1: how you arrive at the 10mg dose

Treatment with Mounjaro begins at 2.5mg, a starting strength chosen specifically to let your body adjust to the medicine rather than to drive weight loss straight away. From there, the prescriber increases the dose roughly every four weeks: 2.5mg, then 5mg, then 7.5mg, and then 10mg. Each step up is conditional on tolerating the previous dose reasonably well. If nausea or other side effects are significant at any stage, staying on the current dose for longer is a legitimate clinical choice.

So by the time you reach Mounjaro 10mg in the UK, you have been on treatment for at least three months. That progression matters because the appetite-suppressing effect of tirzepatide (Mounjaro's active ingredient, a dual GIP and GLP-1 receptor agonist) tends to build across doses. Many people notice the shift in hunger and fullness becoming more pronounced at this point in the sequence. For a fuller picture of what the earlier 5mg step involves, our Mounjaro 5mg page covers that phase in detail.

A practical habit worth building before any dose increase: check your pen's expiry date and lot number against your prescription. It takes under a minute and confirms you have the right strength before you inject.

Step 2: what 10mg Mounjaro actually does in the body

Mounjaro activates two gut-hormone receptors simultaneously (GIP and GLP-1) which work together to slow gastric emptying, signal fullness to the brain and influence how the body handles blood sugar. At 10mg, both pathways are being activated at a meaningfully higher level than at the starter doses. The result, for most people, is a more consistent reduction in appetite across the week, with fewer pronounced hunger windows in the days just before the next injection.

This is also the dose range where the side-effect picture often settles. The gastrointestinal symptoms that tend to peak around dose increases (nausea, loose stools, some reflux) typically become less disruptive once the body has had a few weeks to adjust. That said, a new uptick in GI symptoms after moving from 7.5mg to 10mg is common and usually short-lived. The Mounjaro treatment overview has a thorough breakdown of the side-effect profile across the full schedule, with practical guidance on managing each one.

Tirzepatide is the only dual-agonist weight-loss medicine licensed in the UK, which distinguishes Mounjaro mechanically from semaglutide-based treatments. The NHS provides clear, accessible information on how tirzepatide works and what to watch for, including on its tirzepatide medicines page.

Step 3: results — what the evidence shows at this dose range

In SURMOUNT-1, the pivotal clinical trial published in the New England Journal of Medicine, participants on the highest doses of tirzepatide (10mg and 15mg) achieved average body-weight reductions that were substantially greater than those on lower doses. At 10mg over 72 weeks, average weight loss was in the region of 19–21%, though results varied considerably across individuals. The 15mg group saw slightly higher average reductions still, which is why titration continues for those who tolerate and need it.

It is worth being clear that trial averages are not predictions. The percentage you see reflects a population average from thousands of participants across controlled conditions. Your own result will depend on your starting weight, how closely you follow the dietary and activity guidance, and factors that vary between people. If you are curious about the weight-loss evidence specific to this stage, the Mounjaro 10mg weight-loss page examines the data in more detail.

For those wondering about cost at this or any other dose, the Mounjaro pricing page explains how UK private treatment is structured and what a transparent price should include.

Step 4: moving beyond 10mg, or staying here

Not everyone needs to reach the maximum 15mg dose. Some people find that 10mg produces sufficient appetite reduction and weight-loss progress that their prescriber decides no further increase is warranted. Others move through 10mg to 12.5mg and eventually 15mg if there is clinical reason to do so and they are tolerating the current dose well.

The decision is always made by your prescriber, with your full health picture in view. At nume, every repeat order involves a fresh clinical review, a named prescriber reads your update before any new pen is dispatched, including confirmation of how you are tolerating your current dose. If you are thinking ahead to the next step, our Mounjaro 15mg page covers what that phase involves, and the 10mg pen page answers the most common practical questions about the device itself.

Questions about volume or device mechanics are also common at this dose. How much liquid is in a 10mg pen, and how the clicks relate to your weekly dose, are covered separately: Mounjaro 10mg in ml and pen clicks explained both address this in plain terms. If you have ever wondered whether splitting a dose is safe, half-dosing Mounjaro 10mg explains what the guidance actually says, and why that decision belongs with your prescriber.

If you have questions about where you are in your treatment or whether 10mg is the right next step for you, speaking to our prescribers is the straightforward way to get a clear, personalised answer.